Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04810611
Title Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ISR | ESP | AUS

Facility Status City State Zip Country Details
City Of Hope National Med Center Oncology Duarte California 91010 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Massachusetts General Hospital . Boston Massachusetts 02114 United States Details
The Ohio State University Wexner Medical Center . Columbus Ohio 43210 United States Details
MD Anderson Cancer Center/University of Texas MD Anderson Houston Texas 77030 United States Details
Novartis Investigative Site Prahran Victoria 3181 Australia Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field